register

News - Pharmaceuticals

Electronic prescriptions to support vulnerable Australians during COVID-19 outbreak

Health Industry Hub | March 16, 2020 |

Pharma News: Pharmacists will be able to better support vulnerable patients following the Federal Government’s announcement to fund home medicines services as part of its $2.4 billion COVID-19 health package.

PSA National President Associate Professor Chris Freeman welcomed the Government’s announcement that $25 million will be allocated to fund home medicines services which will enable patients to have their PBS prescriptions filled online or remotely, and have their medicines delivered to their home.

These measures will support the announced telehealth Medicare items for GPs to help contain the spread of the virus and allow GPs to conduct consultations via phone or video.

“However, the effectiveness of this initiative will depend on the successful roll-out of electronic prescription which the Federal Government has committed an additional $5 million of funding to fast track software capability,” he said.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

“PSA has been working with the Government to build capability for electronic prescriptions for many years. Fast-tracking of e-prescriptions is appropriate to ensure people in isolation are able to receive their essential and regular medicines to maintain their health.

PSA supports the approach in fast tracking electronic prescriptions but more needs to be done to support community pharmacy in the adoption and implementation of this initiative.

“This is particularly significant as we know that people with other health conditions, such as cardiovascular disease, are at higher risk of complications of COVID-19.”

Enhance corporate branding and boost thought leadership to attract and retain quality employees. How does your company culture measure up in the Australian Pharma industry? Get the benchmark report by contacting us.

Associate Professor Freeman welcomed the funding of home delivery services as a pragmatic measure to ensure those people unable to leave their homes were not out of pocket at a time they were more likely to be under increased financial stress

“PSA has been working closely with the Federal Government to highlight issues pharmacists on the frontline are experiencing in supporting their patients, including security of medicine supply, the availability of Personal Protective Equipment (PPE), stockpiling of medicines and the continuation of emergency dispensing provisions,” he said.

“We will continue to work with the Government and the Health Minister, Greg Hunt, to ensure the roll-out of these initiatives is practical, effective and well-communicated to the pharmacist workforce.

“PSA will continue to inform the profession the details of these initiatives as they are worked through with the Department of Health.

“Australians look to their pharmacists for their healthcare advice and as frontline health providers it is important that pharmacists are supported by Government so they can continue to provide care for their patients.”

You may also like Prime Minister allocates $2.4b health package to tackle coronavirus in Australia including telehealth in primary care


Digital & Innovation

Health sector faces new privacy obligations

Health sector faces new privacy obligations

Health Industry Hub | September 11, 2026 |

Healthcare organisations must update their privacy policies by 10 December if they use artificial intelligence (AI) or a computer program […]

More


News - Pharmaceuticals

TGA approves new antibiotic but AMR blind spot remains a critical concern

TGA approves new antibiotic but AMR blind spot remains a critical concern

Health Industry Hub | September 11, 2026 |

The Therapeutic Goods Administration (TGA) has approved a new antibiotic for the treatment of carbapenem-resistant Gram-negative bacterial infections. Developed by […]

More


News - MedTech & Diagnostics

BCAL Diagnostics rejects merger speculation

BCAL Diagnostics rejects merger speculation

Health Industry Hub | September 11, 2026 |

ASX-listed BCAL Diagnostics has moved to quash speculation of a potential three-way merger involving Genetic Signatures and Microba Life Sciences, […]

More


News - Pharmaceuticals

Australia backs infectious disease innovation as US funding faces more cuts

Australia backs infectious disease innovation as US funding faces more cuts

Health Industry Hub | September 11, 2026 |

Biointelect Venturer, a national incubator supporting infectious disease innovation, will open its second funding round later this month, with AUD […]

More


This content is copyright protected. Please subscribe to gain access.